Future directions in the treatment of chronic musculoskeletal facial pain: The role of evidence-based care

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 83, Issue 1, 1997, Pages 170-176

  Marbach, Joseph J ^a,b   Raphael, Karen G ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DENTAL EQUIPMENT; EVIDENCE BASED MEDICINE; FACE PAIN; FINANCIAL MANAGEMENT; HUMAN; MYOFASCIAL PAIN; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNNECESSARY PROCEDURE;

EVIDENCE-BASED MEDICINE; FACIAL PAIN; HUMANS; OCCLUSAL SPLINTS; RANDOMIZED CONTROLLED TRIALS; RESEARCH SUPPORT; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME; UNNECESSARY PROCEDURES;

EID: 0030639008     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(97)90110-4     Document Type: Article

References (44)

1. Guyatt GH, Rennie D. Users' guides to the medical literature. JAMA 1993;270:2096-7.
2. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature, II: how to use an article about therapy or prevention - A: are the results of the study valid? JAMA 1993; 270:2598-2601.
3. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature, II: how to use an article about therapy or prevention, B: what were the results and will they help me in caring for my patients? JAMA 1994;271:59-63.
4. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique, J Craniomandib Disord Facial Oral Pain 1992;6:301-55.
5. Marbach JJ. Reaction paper to epidemiology of temporomandibular disorders. In: Sessle BJ, Bryant PS, Dionne RA, editors. Temporomandibular disorders and related pain conditions. Seattle: IASP Press, 1995:245-8.
6. Snow CP. The two cultures and the scientific revolution. New York: Cambridge University Press, 1959:34.
7. Costen JB. A syndrome of ear and sinus symptoms dependent upon disturbed function of the temporomandibular joint. Ann Otolaryngol 1934;43:1-15.
8. Schwartz L. Disorders of the temporomandibular joint. Philadelphia: WB Saunders, 1959.
9. Travell JG, Simons DG. Myofascial pain and dysfunction: the trigger point manual. Baltimore: Williams & Wilkins, 1983.
10. Dawson PE. Evaluation, diagnosis, and treatment of occlusal problems. 2nd ed. St Louis: Mosby, 1989.
11. Clark GT, Seligman D, Solberg W, Pullinger A. Guidelines for the treatment of temporomandibular disorders. J Craniomandib Disord Facial Oral Pain 1990;4:80-8.
12. Glass EG, Glaros AG, McGlynn FD. Myofascial pain dysfunction: treatments used by ADA members. J Craniomandib Pract 1993;11:25-9.
13. Mohl N, Ohrbach R. The dilemma of scientific knowledge versus clinical management of temporomandibular disorders. J Prosthet Dent 1992;67:113-20.
14. Weiss T. Opening Statement. In: Weiss T, ed. Are FDA and NIH ignoring the dangers of TMJ (jaw) implants? Washington (DC): United States Government Printing Office, 1993: 1-4.
15. Management of temporomandibular disorders. J Am Dent Assoc 1996;127:1595-603.
16. Burkhardt F. Charles Darwin's letters: a selection, 1825-1859. Cambridge: Cambridge University Press, 1996:2.
17. Wennberg JE. Dealing with medical practice variations: a proposal for action. Health Aff 1984;3:6-31.
18. Marbach JJ, Raphael KG. Treatment of orofacial pain using evidence-based medicine: the case for intraoral appliances. In: Campbell JN, editor. Pain 1996: an updated review. Seattle: IASP Press, 1996:413-22.
19. Dao TTT, Lavigne GJ, Charbonneau A, Feine JS, Lund JP. The efficacy of oral splints in the treatment of myofascial pain of the jaw muscles: a controlled clinical trial. Pain 1994;45:85-94.
20. Turk DC, Zaki HS, Rudy TE. Effects of intraoral appliance and biofeedback/stress management alone and in combination in treating pain and depression in patients with temporomandibular disorders. J Prosthet Dent 1993;70:158-64.
21. Beard CC, Clayton JA. Effect of occlusal splint therapy on TMJ dysfunction. J Prosthet Dent 1980;44:324-35.
22. Goharian RK, Neff PA. Effect of occlusal retainers on temporomandibular joint and facial pain. J Prosthet Dent 1980; 44:206-8.
23. Okeson JP, Kemper JT, Moody PM. A study of the use of occlusion splints in the treatment of acute and chronic patients with craniomandibular disorders. J Prosthet Dent 1982;48: 708-12.
24. Raphael KG, Marbach JJ. A year of chronic TMPDS: evaluating patients' pain patterns. J Am Dent Assoc 1992;123: 53-8.
25. Laskin DM, Greene CS. Influence of the doctor-patient relationship on placebo therapy for patients with myofascial pain-dysfunction (MPD) syndrome. J Am Dent Assoc 1972; 85:892-4.
26. McDonald CT, Mazzuca SA, McCabe GP. How much of the placebo "effect" is really statistical regression? Statistics Med 1983;4:417-27.
27. Whitney C, Von Korff M. Magnitude of regression to the mean in before-after treatment comparisons of chronic pain. Pain 1992;50:281-5.
28. Clark GT. A critical evaluation of orthopedic interocclusal appliance therapy: design, theory, and overall effectiveness. J Am Dent Assoc 1984;108:359-68.
29. Goss AN. Toward an international consensus on temporomandibular joint surgery. Int J Oral Maxillofac Surg 1993;22: 78-81.
30. VanSickels JE, Dolezal J. Clinical outcome of arthrotomy after failed arthroscopy. Oral Surg Oral Med Oral Pathol 1994;78:142-5.
31. Henry CH, Wolford LM. Treatment outcomes for temporomandibular joint reconstruction after proplast teflon implant failure. J Oral Maxillfac Surg 1993;51:133-42.
32. Brandrick JP, Indresano AT. Failure rate of repetitive temporomandibular joint surgical procedures. J Oral Maxillofac Surg 1992;50(Suppl 3): 145.
33. Trumpy IG, Lyberg T. In vivo deterioration of proplast-teflon temporomandibular joint interpositional implants: a scanning electron microscopic and energy-dispersive x-ray analysis. J Oral Maxillofac Surg 1993;51:624-9.
34. Fontenot MG. Statement of Mark G Fontenot. In: Weiss T, editor. Are FDA and NIH ignoring the dangers of TMJ (jaw) implants? Washington (DC): United States Government Printing Office, 1993:28-36.
35. Gelb LN. FDA notifies physicians and patients about risks of TMJ implants. FDA Med Bull 1991;21:2-3.
36. Henry CH, Wolford LM. Treatment outcomes for temporomandibular joint reconstruction after proplast teflon implant failure. J Oral Maxillfac Surg 1993;51:133-42.
37. Antczak-Bouckoms A. Quality and effectiveness issues related to oral health. Med Care 1995;33(11 Suppl):NS123-42.
38. Laskin DM. Statement of Daniel M. Laskin. In: Weiss T, ed. Are FDA and NIH ignoring the dangers of TMJ (jaw) implants? Washington (DC) United States Government Printing Office, 1993:48-51.
39. Lipton JA, Ship JA, Larbach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993;124:115-21.
40. Dionne R. Pharmacologic treatments for temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;82:134-42.
41. Marbach JJ, Wallenstein, SL. Analgesic, mood and hemodynamic effects if intranasal cocaine and lidocaine in chronic facial pain of deafferentation and myofascial origin. J Pain Sympt Manage 1988;3:1-7.
42. Portenoy RK. Opioid therapy for chronic nonmalignant pain: current status. In: Fields HL, Liebeskind JC, editors. Progress in pain research and management. Vol. 1. Pharmacological approaches to the treatment of chronic pain: new concepts and critical issues. Seattle: IASP Publications, 1994:247-87.
43. Antczak-Bouckoms A. Meta-analysis of therapy for temporomandibular disorders, IV: discussion and conclusions. In: Weiss T, editor. Are FDA and NIH ignoring the dangers of TMJ (jaw) implants? Washington (DC) United States Government Printing Office, 1993:334-6.
44. Jadad AR. Systematic reviews and meta-analyses in pain relief research: what can (and cannot) they do for us? In: Campbell JN, editor. Pain 1996: an updated review. Seattle: IASP Press, 1996:445-52.